http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
결핵성 수막염 환자에서 결핵균 30 kDa 및 32 kDa 단백항원에 대한 항체반응의 비교
백태현,김선영,이건수,김화중,김성호,조은경,박정규 충남대학교 의과대학 지역사회의학연구소 1996 충남의대잡지 Vol.23 No.2
The 30 and 32 kDa antigens from Mycobacterium tuberculosis H37Rv culture filtrates, identified as biologically important proteins in the immune responses against mycobacterial infection, were purified and used in enzyme linked ummunosorbent assay (ELISA) for the determination in specific IgG and IgM levels in cerebrospinal fluids of 15 patients with tuberculous meningitis and 17 controls with nontuberculous diseases. High reactivity to both antigens was observed in tuberculous meningitis. Mean IgG and IgM antibody levels differed significantly (P < 0.001) between patients and con trols. Mean IgG antibody levels were also higher than IgM levels in tuberculous meningitis. A comparison of the antibody levels against the 30 and 32 kDa antigen within the tuberculous meningitis patients showed higher IgG reactivity to the 30 kDa than to the 32 kDa antigen, suggesting that the antibody response of these patients is directed predominantly against the 30 kDa protein. However, the patterns of reactivity to 30/32 kDa, 30 kDa and 32 kDa antigen in individual subjects were similar. By the cut-off value adding 2 stsndard deviation to the mean absorbance of controls, the sensitivity and specificity of the IgG antibody to the 30 kDa antigen were 100% and 94.4%, respectively. These values were higher than those obtained by 30/ 32 kDa and 32 kDa antigen. From the above results, it is suggested that the 30 kDa antigen may be dominant antigen and more valuable in the diagnosis of tuberculous meningitis than 32 kDa antigen.
Eun Jung Rhee,Hyun SikJeong,Seung Sei Lee 대한암학회 2002 Cancer Research and Treatment Vol.34 No.1
Purpose: To evaluate the efficacy and toxicity of thecombination therapy of paclitaxel and cisplatin in advanced,non-small cell, lung cancer patientsMaterials and Methods: Between December 1997 andSeptember 2001, 37 patients with advanced, non-smallcell, lung cancer were enrolled in this study. Patientswere treated with paclitaxel (135 mg/m2, 24 hr infusion)and cisplatin (75 mg/m2). The treatments were repeatedevery 4 weeks.Results: Among the 37 patients enrolled, 21 weretreated with paclitaxel and cisplatin as a first-line and 16patients as a second-line. The median age of the patientswas 59. In the first-line group, 10 had stage IIIB and 11had stage IV, non small cell lung cancer. Of 21 patientsin first-line treatment group that could be evaluated,objective responses were observed in 6 patients (responserate: 28.6%, CR: 4.8%, PR: 23.8%). The mediansurvival duration for patients was 48 weeks. With thesecond-line group, 3 patients showed a partial response(response rate: 18.7%) to treatment, with median survivalduration of 44 weeks. Grade 3∼4 leukopenia was observedin 27.1% of the first-line, and 23.6% in second- line,treatment groups.Conclusion: Combination chemotherapy, with paclitaxeland cisplatin, in non-small cell lung cancer has acceptabletoxicities in both first and second-line treatment groups.In terms of efficacy, no superior response was shown foreither group. More randomized studies, with a larger groupof patients, are required to prove the true efficacy. (Cancer Res Treat. 2002;34:28-33)
Jung, Eun-Mi,Rhee, Young-Woo,Peck, Dong-Hyun,Lee, Byoung-Rok,Kim, Sang-Kyung,Jung, Doo-Hwan The Korean Electrochemical Society 2008 한국전기화학회지 Vol.11 No.1
A Pt-layer was deposited on the anode side of a Nafion membrane via a sputtering method in order to reduce methanol crossover in a direct methanol fuel cell (DMFC). The methanol permeation and the proton conductivity through the modified membranes were investigated. The performances of the direct methanol fuel cell were also tested using single cells with a Nafion membrane and the modified membranes. The Pt-layers on the membrane blocked both methanol crossover and proton transport through the membranes. Methanol permeability and proton conductivity decreased with an increase of the platinum layer thickness. At methanol concentration of 2 M, the DMFC employing the modified membrane with a platinum layer of 66 nm-thickness showed similar performance to that of a DMFC with a bare Nafion membrane in spite of the lower proton conductivity of the former. The maximum power density of the cell using the modified membrane with a platinum layer of 66 nm-thickness increased slightly while that of the cell with the bare membrane decreased abruptly when a methanol solution of 6M was supplied.
A Report of Journal of Obesity and Metabolic Syndrome in the Last 3 Years of Upheaval
Eun-Jung Rhee 대한비만학회 2022 The Korean journal of obesity Vol.31 No.1
Journal of Obesity and Metabolic Syndrome (JOMES) is the official journal of the Korean Society for the Study of Obesity (KSSO) and is a peer-reviewed research journal that presents relevant academic research and the newest medical information in the field of obesity. JOMES was launched in 1992, with the foundation of the KSSO and diverse studies on obesity published under the title Journal of the KSSO until 2004. Since its publication in full English in 2017, JOMES was rapidly registered in numerous databases, that is, in PubMed Central in 2018, in Emerging Sources Citation Index (ESCI) and in Scopus in 2019. In addition, JOMES is indexed in KoreaMed, Science Central, EBSCO, DOAJ, and Google Scholar. The increase in the number of citations of JOMES within Web of Science is astonishing, and the world is reading and citing JOMES. In this review, I’d like to review the current status of JOMES and share the rapid development of JOMES with readers and potential authors of JOMES.
Metabolism-Based Medical and Surgical Interventions for Nonalcoholic Fatty Liver Disease
( Eun-jung Rhee ) 대한간학회 2021 Postgraduate Courses (PG) Vol.2021 No.1
Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of insulin resistance and ectopic fat infiltration. Increased release of fatty acid from adipose tissue due to absence of protective effect of insulin on lipolysis leads to ectopic accumulation of fatty acids on various organs in our body. Therefore, presence of NAFLD in a subject shows presence of insulin resistance that exceeds the flexibility of adipose tissue to expand to preserve remnant energy. Standard treatment of choice of NAFLD is weight loss. Among various anti-diabetic agents, thiazolidinedione, a potent insulin sensitizer is the only officially recommended agent for NAFLD. Other agents that causes weight loss, that is, GLP-1 receptor agonists and SGLT2 inhibitor, show positive results on treatment of NAFLD. For bariatric surgery, studies until now are not enough for firm results for treatment of NAFLD. In this talk, I would like to summarize the treatment effects of bariatric surgery and anti-diabetic medications on NAFLD.
2018 Guidelines for the management of dyslipidemia in Korea
( Eun-Jung Rhee ),( Hyeon Chang Kim ),( Jae Hyeon Kim ),( Eun Young Lee ),( Byung Jin Kim ),( Eun Mi Kim ),( YoonJu Song ),( Jeong Hyun Lim ),( Hae Jin Kim ),( Seonghoon Choi ),( Min Kyong Moon ),( Ji 대한내과학회 2019 The Korean Journal of Internal Medicine Vol.34 No.5
Rhee, Eun Jung,Oh, Ki Won,Jung, Chan Hee,Lee, Won Young,Oh, Eun Sook,Yun, Eun Joo,Baek, Ki Hyun,Kang, Moo Il,Kim, Sun Woo Blackwell Publishing Ltd 2006 Clinical endocrinology Vol.64 No.6
<P>Summary</P><P>Objective </P><P>Osteoprotegerin (OPG) is a recently identified cytokine that acts as a decoy receptor for the receptor activator of the NF-&kgr;B ligand (RANKL). OPG has been shown to be an important inhibitor of osteoclastogenesis and arterial calcification in animal models. OPG has been proposed as a link molecule between osteoporosis and arterial calcification, but the relationship between the OPG gene and the cardiovascular system in human populations is unclear. Thus, the aim of this study was to investigate the relationship between OPG gene polymorphisms and aortic calcification or coronary artery disease in Koreans.</P><P>Design and patients </P><P>Genotyping of four polymorphisms, A163G, G209A, T245G and T950C, in the promoter region of the OPG gene was performed in 251 healthy Korean women (mean age 51·3 ± 6·9 years) and in a second study population consisting of 100 patients who underwent coronary angiography (mean age 57·0 ± 11·9 years), by allelic discrimination using the 5′ nuclease polymerase chain reaction assay. Cardiovascular risk factors and serum OPG levels were measured and aortic calcification in thoracic and abdominal aorta was examined by simple radiological methods.</P><P>Results </P><P>In the first study population, the prevalence of aortic calcification increased significantly as the subjects grew older. The frequencies of mutant alleles were significantly higher in the subjects with aortic calcification compared with those without aortic calcification in G209A and T950C polymorphisms, although these significances were lost after adjustment for age. No significant relationship was found between OPG gene polymorphisms and serum OPG levels or cardiovascular risk factors. In the second study group, there were no associations between OPG promoter genotypes and aortic calcification, serum OPG levels, or coronary artery disease.</P><P>Conclusions </P><P>We observed that the four polymorphisms in the promoter region of the OPG gene were not associated with aortic calcification or coronary artery disease in Koreans. Further studies are needed to clarify this relationship.</P>